Vascular Graft Infections

Infectious Disease Clinics of North America

Volumn 26, Issue 1, 2012, Pages 41-56

  Young, Michael H ^a   Upchurch, Gilbert R ^b   Malani, Preeti N ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Arterial graft; Biofilms; Prosthetic graft; Vascular graft infection

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CEFTAZIDIME; CHLORHEXIDINE; DAPTOMYCIN; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TIMENTIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; AORTA GRAFT; ASEPSIS; BACTERIUM CONTAMINATION; BLOOD VESSEL GRAFT; BONE MARROW SUPPRESSION; CATHETER INFECTION; CATHETER THROMBOSIS; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DEBRIDEMENT; DIAGNOSTIC PROCEDURE; DIARRHEA; DRUG EFFECT; ERADICATION THERAPY; GRAFT INFECTION; GRAFT PRESERVATION; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HEMODIALYSIS; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; POSTOPERATIVE INFECTION; RASH; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TREATMENT PLANNING; VACUUM ASSISTED CLOSURE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; HUMANS; RISK FACTORS;

EID: 84856256822     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2011.09.004     Document Type: Review

References (68)

1. Wilson S.E. New alternatives in management of the infected vascular prosthesis. Surg Infect (Larchmt) 2001, 2:171-175.
2. Herscu G., Wilson S.E. Prosthetic infection: lessons from treatment of the infected vascular graft. Surg Clin North Am 2009, 89:391-401.
3. Chang J.K., Calligaro K.D., Ryan S., et al. Risk factors associated with infection of lower extremity revascularization: analysis of 365 procedures performed at a teaching hospital. Ann Vasc Surg 2003, 17:91-96.
4. Pounds L.L., Montes-Walters M., Mayhall C.G., et al. Achanging pattern of infection after major vascular reconstructions. Vasc Endovascular Surg 2005, 39:511-517.
5. Ryan S.V., Calligaro K.D., Scharff J., et al. Management of infected prosthetic dialysis arteriovenous grafts. JVasc Surg 2004, 39:73-78.
6. Darouiche R.O. Treatment of infections associated with surgical implants. NEngl J Med 2004, 350:1422-1429.
7. Calligaro K.D., Veith F.J., Schwartz M.L., et al. Selective preservation of infected prosthetic arterial grafts. Analysis of a 20-year experience with 120 extracavitary-infected grafts. Ann Surg 1994, 220:461-469.
8. Edwards W.H., Martin R.S., Jenkins J.M., et al. Primary graft infections. JVasc Surg 1987, 6:235-239.
9. Jensen L.J., Kimose H.H. Prosthetic graft infections: a review of 720 arterial prosthetic reconstructions. Thorac Cardiovasc Surg 1985, 33:389-391.
10. Mertens R.A., O'Hara P.J., Hertzer N.R., et al. Surgical management of infrainguinal arterial prosthetic graft infections: review of a thirty-five-year experience. JVasc Surg 1995, 21:782-790.
11. Taylor M.D., Napolitano L.M. Methicillin-resistant Staphylococcus aureus infections in vascular surgery: increasing prevalence. Surg Infect (Larchmt) 2004, 5:180-187.
12. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
13. Schierholz J.M., Beuth J. Implant infections: a haven for opportunistic bacteria. JHosp Infect 2001, 49:87-93.
14. Zimmerli W., Waldvogel F.A., Vaudaux P., et al. Pathogenesis of foreign body infection: description and characteristics of an animal model. JInfect Dis 1982, 146:487-497.
15. Costerton J.W., Post J.C., Ehrlich G.D., et al. New methods for the detection of orthopedic and other biofilm infections. FEMS Immunol Med Microbiol 2011, 61:133-140.
16. Calligaro K.D., Syrek J.R., Dougherty M.J., et al. Use of arm and lesser saphenous vein compared with prosthetic grafts for infrapopliteal arterial bypass: are they worth the effort?. JVasc Surg 1997, 26:919-924.
17. Lee E.S., Santilli S.M., Olson M.M., et al. Wound infection after infrainguinal bypass operations: multivariate analysis of putative risk factors. Surg Infect (Larchmt) 2000, 1:257-263.
18. Pedersen G., Laxdal E., Hagala M., et al. Local infections after above-knee prosthetic femoropopliteal bypass for intermittent claudication. Surg Infect (Larchmt) 2004, 5:174-179.
19. Antonios V.S., Noel A.A., Steckelberg J.M., et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. JInfect 2006, 53:49-55.
20. Fiorani P., Speziale F., Calisti A., et al. Endovascular graft infection: preliminary results of an international enquiry. JEndovasc Ther 2003, 10:919-927.
21. Vriesendorp T.M., Morelis Q.J., Devries J.H., et al. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endovasc Surg 2004, 28:520-525.
22. Vogel T.R., Symons R., Flum D.R. The incidence and factors associated with graft infection after aortic aneurysm repair. JVasc Surg 2008, 47:264-269.
23. Calligaro K.D., Veith F.J., Schwartz M.L., et al. Recommendations for initial antibiotic treatment of extracavitary arterial graft infections. Am J Surg 1995, 170:123-125.
24. Nasim A., Thompson M.M., Naylor A.R., et al. The impact of MRSA on vascular surgery. Eur J Vasc Endovasc Surg 2001, 22:211-214.
25. Collazos J., Mayo J., Martinez E., et al. Prosthetic vascular graft infection due to Aspergillus species: case report and literature review. Eur J Clin Microbiol Infect Dis 2001, 20:414-417.
26. Lephart P., Ferrieri P., van Burik J.A. Reservoir of Candida albicans infection in a vascular bypass graft demonstrates a stable karyotype over six months. Med Mycol 2004, 42:255-260.
27. Matthay R.A., Levin D.C., Wicks A.B., et al. Disseminated histoplasmosis involving an aortofemoral prosthetic graft. JAMA 1976, 235:1478-1479.
28. Raffetto J.D., Bernardo J., Menzoian J.O. Aortobifemoral graft infection with Mycobacterium tuberculosis: treatment with abscess drainage, debridement, and long-term administration of antibiotic agents. JVasc Surg 2004, 40:826-829.
29. Zetrenne E., McIntosh B.C., McRae M.H., et al. Prosthetic vascular graft infection: a multi-center review of surgical management. Yale J Biol Med 2007, 80:113-121.
30. Soetevent C., Klemm P.L., Stalenhoef A.F., et al. Vascular graft infection in aortoiliac and aortofemoral bypass surgery: clinical presentation, diagnostic strategies and results of surgical treatment. Neth J Med 2004, 62:446-452.
31. FitzGerald S.F., Kelly C., Humphreys H. Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus. JAntimicrob Chemother 2005, 56:996-999.
32. Nassar G.M., Ayus J.C. Clotted arteriovenous grafts: a silent source of infection. Semin Dial 2000, 13:1-3.
33. Orton D.F., LeVeen R.F., Saigh J.A., et al. Aortic prosthetic graft infections: radiologic manifestations and implications for management. Radiographics 2000, 20:977-993.
34. Thomas P., Forstrom L. In-111 labeled purified granulocytes in the diagnosis of synthetic vascular graft infections. Clin Nucl Med 1994, 19:1075-1078.
35. Rossi P., Arata F.M., Salvatori F.M., et al. Prosthetic graft infection: diagnostic and therapeutic role of interventional radiology. JVasc Interv Radiol 1997, 8:271-277.
36. Seify H., Moyer H.R., Jones G.E., et al. The role of muscle flaps in wound salvage after vascular graft infections: the Emory experience. Plast Reconstr Surg 2006, 117:1325-1333.
37. Calligaro K.D., Veith F.J., Schwartz M.L., et al. Differences in early versus late extracavitary arterial graft infections. JVasc Surg 1995, 22:680-685.
38. O'Connor S., Andrew P., Batt M., et al. Asystematic review and meta-analysis of treatments for aortic graft infection. JVasc Surg 2006, 44:38-45.
39. Young R.M., Cherry K.J., Davis P.M., et al. The results of in situ prosthetic replacement for infected aortic grafts. Am J Surg 1999, 178:136-140.
40. Calligaro K.D., Veith F.J., Sales C.M., et al. Comparison of muscle flaps and delayed secondary intention wound healing for infected lower extremity arterial grafts. Ann Vasc Surg 1994, 8:31-37.
41. Dosluoglu H.H., Schimpf D.K., Schultz R., et al. Preservation of infected and exposed vascular grafts using vacuum assisted closure without muscle flap coverage. JVasc Surg 2005, 42:989-992.
42. Lehnert T., Gruber H.P., Maeder N., et al. Management of primary aortic graft infection by extra-anatomic bypass reconstruction. Eur J Vasc Surg 1993, 7:301-307.
43. Hart J.P., Eginton M.T., Brown K.R., et al. Operative strategies in aortic graft infections: is complete graft excision always necessary?. Ann Vasc Surg 2005, 19:154-160.
44. Calligaro K.D., Veith F.J. Graft preserving methods for managing aortofemoral prosthetic graft infection. Eur J Vasc Endovasc Surg 1997, 14(Suppl A):38-42.
45. Menawat S.S., Gloviczki P., Serry R.D., et al. Management of aortic graft-enteric fistulae. Eur J Vasc Endovasc Surg 1997, 14(Suppl A):74-81.
46. Belair M., Soulez G., Oliva V.L., et al. Aortic graft infection: the value of percutaneous drainage. AJR Am J Roentgenol 1998, 171:119-124.
47. Keeling W.B., Myers A.R., Stone P.A., et al. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections. JSurg Res 2009, 157:223-226.
48. Stone P.A., Armstrong P.A., Bandyk D.F., et al. Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections. JVasc Surg 2006, 44:757-761.
49. Saleem B.R., Meerwaldt R., Tielliu I.F., et al. Conservative treatment of vascular prosthetic graft infection is associated with high mortality. Am J Surg 2010, 200:47-52.
50. Greenhalgh R.M., Brown L.C., Powell J.T., et al. Endovascular versus open repair of abdominal aortic aneurysm. NEngl J Med 2010, 362:1863-1871.
51. Hobbs S.D., Kumar S., Gilling-Smith G.L. Epidemiology and diagnosis of endograft infection. JCardiovasc Surg (Torino) 2010, 51:5-14.
52. Laser A., Baker N., Rectenwald J., et al. Graft infection after endovascular abdominal aortic aneurysm repair. JVasc Surg 2011, 54(1):58-63.
53. Cernohorsky P., Reijnen M.M., Tielliu I.F., et al. The relevance of aortic endograft prosthetic infection. JVasc Surg 2011, 54(2):327-333.
54. Ducasse E., Calisti A., Speziale F., et al. Aortoiliac stent graft infection: current problems and management. Ann Vasc Surg 2004, 18:521-526.
55. Zetrenne E., Wirth G.A., McIntosh B.C., et al. Managing extracavitary prosthetic vascular graft infections: a pathway to success. Ann Plast Surg 2006, 57:677-682.
56. Nassar G.M., Ayus J.C. Infectious complications of the hemodialysis access. Kidney Int 2001, 60:1-13.
57. Schild A.F., Simon S., Prieto J., et al. Single-center review of infections associated with 1,574 consecutive vascular access procedures. Vasc Endovascular Surg 2003, 37:27-31.
58. Zimmerli W., Widmer A.F., Blatter M., et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998, 279:1537-1541.
59. Martinez-Pastor J.C., Munoz-Mahamud E., Vilchez F., et al. Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis. Antimicrob Agents Chemother 2009, 53:4772-4777.
60. Terpling S., Schade Larsen C., Schonheyder H.C. Long-term home-based parenteral antibiotic treatment of a prosthetic vascular graft infection caused by Pseudomonas aeruginosa. Scand J Infect Dis 2006, 38:388-392.
61. Mussa F.F., Hedayati N., Zhou W., et al. Prevention and treatment of aortic graft infection. Expert Rev Anti Infect Ther 2007, 5:305-315.
62. Hoffman-Terry M.L., Fraimow H.S., Fox T.R., et al. Adverse effects of outpatient parenteral antibiotic therapy. Am J Med 1999, 106:44-49.
63. Bandyk D.F. Vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg 2008, 21:119-123.
64. Anderson D.J., Kaye K.S., Classen D., et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S51-S61.
65. Stewart A., Eyers P.S., Earnshaw J.J. Prevention of infection in arterial reconstruction. Cochrane Database Syst Rev 2006, 3. CD003073.
66. Coates T., Bax R., Coates A. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. JAntimicrob Chemother 2009, 64:9-15.
67. Robicsek A., Beaumont J.L., Thomson R.B., et al. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 2009, 30:623-632.
68. Bode L.G., Kluytmans J.A., Wertheim H.F., et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. NEngl J Med 2010, 362:9-17.